Chemosensitivity of prostatic tumour cell lines under conditions of G2 block abrogation (original) (raw)
Abstract
Conventional chemotherapy has had very limited success in the control of hormone-refractory prostate cancer. Methylxanthine derivatives, such as pentoxifylline (PTX), are known to abrogate the G2 block and enhance the toxicity of ionising irradiation and chemotherapeutic agents. It is now also established that late addition of the cytotoxic drug after irradiation under conditions of G2 block abrogation sensitises human tumour cells for cytotoxins. Here we assess whether the chemosensitivity of prostate tumour cell lines can be enhanced by the application of a low dose of drug in conjunction with a G2 block abrogator. Prostate cell lines DU145, BM1604 and LNCaP were irradiated with 7 Gy 60Co γ-irradiation. A sub-toxic (2 mM) dose of pentoxifylline and a cytotoxic drug were added at maximum expression of the G2 cell cycle block and cell survival was determined by colony assay. Cisplatin, etoposide and vinblastine were tested at a toxic dose of 10% (TD10). In the TP53 mutant cell lines, DU145 and BM1604, dose enhancement factors (EFs) were found to be in the region of 4.20 for cisplatin, 3.70 for vinblastine, and 3.20 for etoposide. In the TP53 wild-type cell line, LNCaP, the enhancement factors were low and in the region of 1.20 for cisplatin, vinblastine and etoposide. It is clear, therefore, that toxicity enhancement factors (EFs) are greater in the TP53 mutant cell lines, DU145 and BM1604, than in the TP53 wild-type cell line, LNCaP. The results indicate that a significant enhancement of drug toxicity can be obtained if the cytotoxic drug is given under conditions of G2 block abrogation. The sensitisation of prostate cancer cells to cytotoxic drugs is particularly high in radiation-resistant TP53 mutant tumour cells. Drugs which abrogate G2 block have the potential to enhance the therapeutic index and therefore reduce the toxicity of chemotherapy drugs.
Access this article
Subscribe and save
- Starting from 10 chapters or articles per month
- Access and download chapters and articles from more than 300k books and 2,500 journals
- Cancel anytime View plans
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Similar content being viewed by others
Author information
Authors and Affiliations
- Department of Radiation Oncology, Radiobiology Laboratory, University of Stellenbosch Medical Faculty, P.O. Box 19063, Tygerberg 7505, South Africa e-mail: elb@gerga.sun.ac.za Tel.: +27-21-9389539; Fax: +27-21-9338886, , , , , , ZA
Antonio M. Serafin, Anke B. Binder & Lothar Böhm
Authors
- Antonio M. Serafin
- Anke B. Binder
- Lothar Böhm
Additional information
Received: 23 November 2000 / Accepted: 23 February 2001
Rights and permissions
About this article
Cite this article
Serafin, A., Binder, A. & Böhm, L. Chemosensitivity of prostatic tumour cell lines under conditions of G2 block abrogation.Urological Research 29, 221–227 (2001). https://doi.org/10.1007/s002400100186
- Issue date: June 2001
- DOI: https://doi.org/10.1007/s002400100186